Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
百梅止咳颗粒
- Development stage
- Unknown
- Lead developer
- Henan Bainian Kangxin Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
百梅止咳颗粒 (Bai Mei Zhi Ke Keli) is a traditional Chinese medicine (TCM) oral granule developed and marketed by Henan Bainian Kangxin Pharmaceutical. It is an approved pharmaceutical product in China indicated for the relief of cough and respiratory symptoms, particularly those associated with chronic conditions or lung yin deficiency. The formulation is a combination of several herbal extracts, including *Stemonae Radix* (Baibu), *Mume Fructus* (Wumei), *Armeniacae Semen Amarum* (Kuxingren), *Platycodonis Radix* (Jiegeng), and *Glycyrrhizae Radix* (Gancao). These ingredients work synergistically to provide antitussive, expectorant, and anti-inflammatory effects by moistening the respiratory tract and suppressing the cough reflex. As a TCM product, it is distributed through franchise and retail channels in China.
- Brand names
- 百梅止咳颗粒
- Other names
- Bai Mei Zhi Ke KeliBai Mei Cough-Relief Granules
Beyond the preview
Go deeper on 百梅止咳颗粒.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 百梅止咳颗粒.